 |
|
|
| |
Avoiding the Impact of Inaction: How to Maximize Progress to HCV Elimination in the United States
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Nancy Reau1*, Zach Baldwin2, Barbra Cave2,
Yuri Sanchez Gonzalez2, Mark Sulkowski3
1Rush University Medical Center, Chicago, IL, USA; 2AbbVie Inc., North Chicago, IL, USA; 3Johns Hopkins University School of Medicine, Baltimore, MD, USA
*Presenting author
|
| |
|
|
|
|
|
